Global Radiotherapy Devices Market Research Report
- Report Code: RA 1000
- Publish Date: Upcoming
The global radiotherapy market is driven by changing cancer treatment technology and growing number of cancer patients. The market value was $5,028 million in 2013 and estimated to be $5,880 million by 2018, at a CAGR of 3.20%. The external beam radiotherapy market is the largest segment of $4,108 million radiotherapy device market.
The report “Global Radiotherapy Market Forecast, 2012-2018”, analyzes the market of devices by three segments such as external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. All the segments would experience a positive growth till 2018 with an increase in cancer patient pool, increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $4,108 million and $471 million, external beam radiotherapy and internal beam radiotherapy segments have been contributing with a market share of 81.7% and 9.4%, respectively in terms of total radiotherapy devices market. Both the markets have been witnessing maximum growth because of increase in cancer patient pool. Internal Beam Radiotherapy Market is the Second Largest segment. Higher energy linear accelerators dominate the global radiotherapy market in different forms such as with conventional IMRT, IGRT, and stereotactic technology. After the U.S. market, Europe and BRIC nations are the only potential markets to sustain this therapeutic procedure.
In North America (US, Canada), Europe (Germany, France, Italy, Spain, UK), and Asia (India, China, Japan) the rising rates of cancer population have been driving the market growth. The market growth is higher in North America because it is always inclined to the newer techniques while comparatively slow-moving markets such as Europe and Japan are emerging using both old and new technologies. North America is the most dynamic, highly competitive and the largest market for radiotherapy devices globally. The U.S. and Europe comprise the maximum share of this market but developing countries such as in Asian and other regions of the world are adopting new policies to welcome this therapeutic procedure to fight against cancer.
Prevalence of Cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, with a male and female ratio of 10:9. In 2012, there were approximately 14.1 million new cases of cancer in the world. In 2014, there is an estimate of 1,665,540 new cancer cases to be diagnosed and witness 585,720 cancer deaths in the US alone. Cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths. The report also provides an extensive competitive landscaping of companies operating in this market.
The main companies operating in radiotherapy market covered in this report are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, and Covidien Ltd. The details of the segment and country-specific company shares, news and deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies is covered in the report.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence and patient pool with different types of cancer affecting different parts of the body such as male prostate gland, female breast and genitals, lungs, head and neck, colon, rectum, spine, and brain
- Disease progression (pattern analysis)
Procedure Volume Data
- Surgeries of cancer in prostate gland, brain, lungs, head, and neck are performed annually in each country tracked till sub-segment level.
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost Analysis of radiotherapy devices in various countries.
- Procedural investment in major countries mainly for cancer in prostate gland of a male, brain, lungs, head, and neck.
Competitive Intelligence
- The company share analysis of radiotherapy devices for the top players of the market in the region.
- The crucial developments and strategies of companies inculcating in their portfolio for radiotherapy devices.
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Cancer Centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Prostate Cancer
4.2 Breast and female genital organs Cancers
4.3 Cervical Cancer
4.4 Penile Cancer
4.5 Lung and pleura Cancers
4.6 Esophageal Cancer
4.7 Head and neck cancers
4.8 Colorectal Cancer
4.9 Spine Cancer
5 By Products
5.1 External Beam Radiotherapy
5.2 Internal Beam Radiotherapy/Brachytherapy
5.3 Systemic Radiotherapy
6 By Geographies
6.1 North America
6.2 Europe
6.3 Asia
6.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Global External Beam Radiotherapy Market The Global External Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $4108 million in 2013 and expected to be $4820 million by 2018, growing at a CAGR of 3.2%. The External Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Global Internal Beam Radiotherapy/Brachytherapy Market The Global Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $471million in 2013 and expected to be $532million by 2018, growing at a CAGR of 2.5%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Internal Beam Radiotherapy/Brachytherapy are Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Global Systemic Radiotherapy Market The Global Systemic Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients and mainly its applications in thyroid cancer, bone metastasis, radio immunotherapy and non-Hodgkin’s lymphoma.The Market was pegged at $436.5 million in 2013 and expected to be $527 million by 2018, growing at a CAGR of 3.8%.The Systemic Radiotherapy Market analyzes the market of devices by 5 segments such as Iodine-131, Samarium-153, Rhenium-186, Erbium-169 and Yttrium-90.The prominent players in the Systemic Radiotherapy Devices Market globally are Nordion, IBA SA, Polatum, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Global Compact Advanced Radiotherapy Systems Market The Global Compact Advance Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $541 million in 2013 and expected to be $663 million by 2018, growing at a CAGR of 4.1%. The Compact Advance Radiotherapy Systems Market analyzes the market of devices by 3 segments such as Cyberknife, Gamma Knife, and TomoTherapy system.The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Global Proton Radiotherapy Systems Market The Global Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $322 million in 2013 and expected to be $388 million by 2018, growing at a CAGR of 3.8%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Global Electron Emitting High Energy Linear Accelerators (Linac) Systems Market The Global High Energy Linear Accelerators(LINAC) Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $3299 million in 2013 and expected to be $3769 million by 2018, growing at a CAGR of 2.7%. High Energy Linear Accelerators(LINAC) Systems Market analyzes the market of devices by segments by technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy and others. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Global Brachytherapy Seeds Market The Global Brachytherapy Seeds Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $251.4 million in 2013 and expected to be $283.8 million by 2018, growing at a CAGR of 2.5%. The Brachytherapy Seeds Market analyzes the market of devices by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. The prominent players in Brachytherapy Seeds Market globally are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Applicators & Afterloaders Applicators & Afterloaders and Brachytherapy Seeds and |
Upcoming |
|
|
Electronic Brachytherapy Electronic Brachytherapy and Brachytherapy Seeds and |
Upcoming |
|
|
Cyberknife Cyberknife and TomoTherapy and Gamma Knife adds up to total |
Upcoming |
|
|
TomoTherapy TomoTherapy and Cyberknife and Gamma Knife adds up to total |
Upcoming |
|
|
Gamma Knife Gamma Knife and Cyberknife and TomoTherapy adds up to total |
Upcoming |
|
|
Cyclotron for Proton Therapy Cyclotron for Proton Therapy and Synchrotron for Proton Therapy adds up to total |
Upcoming |
|
|
Synchrotron for Proton Therapy Synchrotron for Proton Therapy and Cyclotron for Proton Therapy adds up to total |
Upcoming |
|
|
Cesium-131 Cesium-131 and Iodine-125, Palladium-103 and |
Upcoming |
|
|
Iodine-125 Iodine-125 and Cesium-131, Palladium-103 and |
Upcoming |
|
|
Palladium-103 Palladium-103 and Cesium-131, Iodine-125 and |
Upcoming |
|
|
Iridium-192 Iridium-192 and Cesium-131, Iodine-125 and |
Upcoming |
|
|
North American Radiotherapy Devices Market The North American Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1878.7 million in 2013 and expected to be $2072.9 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European Radiotherapy Devices Market The European Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $915.4 million in 2013 and expected to be $1028.1 million by 2018, growing at a CAGR of 2.3%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
